NEW YORK, Dec. 3, 2015 /PRNewswire/ -- Attorney Advertising
-- Bronstein, Gewirtz & Grossman, LLC is investigating
potential claims on behalf of purchasers of the securities of
Aoxing Pharmaceutical Company, Inc. ("Aoxing Pharmaceutical" or the
"Company") (NYSE -MKT: AXN -News). Such investors are advised
to contact Peretz Bronstein or his
investor relations coordinator Eitan
Kimelman at info@bgandg.com or 212-697-6484.
The investigation concerns whether Aoxing Pharmaceutical and
certain of its officers and/or directors have violated Sections
10(b) and 20(a) of the Securities Exchange Act of 1934.
On December 1, 2015, post-market,
Aoxing reported the resignation of Wilfred
Chow, the Company's Chief Financial Officer, on November 30, 2015. Following this news,
Aoxing Pharmaceutical shares fell $0.07, or 5.11%, to close at $1.30.
If you are aware of any facts relating to this investigation, or
purchased shares of Aoxing Pharmaceutical, you can assist this
investigation by contacting Peretz
Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz &
Grossman, LLC at 212-697-6484 or via email info@bgandg.com.
Those who inquire by e-mail are encouraged to include their mailing
address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
info@bgandg.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-aoxing-pharmaceutical-company-inc-300187633.html
SOURCE Bronstein, Gewirtz & Grossman, LLC
